Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Submitted by
admin
on August 31, 2013 - 11:20am
Source:
Seeking Alpha
News Tags:
Eli Lilly
necitumumab
lung cancer
Headline:
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Do Not Allow Advertisers to Use My Personal information
